Avacta Group (LON:AVCT) Stock Price Up 11.2% - Still a Buy?

Avacta Group Plc (LON:AVCT - Get Free Report)'s share price traded up 11.2% during mid-day trading on Thursday . The stock traded as high as GBX 50.65 ($0.64) and last traded at GBX 49.21 ($0.62). 1,038,627 shares traded hands during mid-day trading, a decline of 56% from the average session volume of 2,346,237 shares. The stock had previously closed at GBX 44.25 ($0.56).

Avacta Group Stock Performance

The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 63.54. The company has a market cap of £168.04 million, a PE ratio of -532.33 and a beta of 1.12. The business's fifty day moving average is GBX 55 and its 200-day moving average is GBX 57.32.

Insider Activity

In related news, insider Tony Peter Gardiner sold 500,000 shares of the business's stock in a transaction dated Friday, August 30th. The shares were sold at an average price of GBX 71 ($0.90), for a total value of £355,000 ($449,196.51). Corporate insiders own 32.90% of the company's stock.

Avacta Group Company Profile

Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.